Centre for Cancer Biomarkers (CCBIO) is a Centre of Excellence at the Faculty of Medicine, University of Bergen.
The center is working on new cancer biomarkers and targeted therapy, and has particular focus on mechanisms that show how cancer cells are affected by the microenvironment in the tumors, and what significance this has for cancer proliferation and poor prognosis. See the 1 minute video CCBIO in a Nutshell. Centre Director is Lars A. Akslen, Department of Clinical Medicine. Read about our research and activities in the CCBIO Annual Report.
CCBIO's principal investigators:
CCBIO Special Seminar – Edward R. Smith
CCBIO is established in 2013 by the Research Council of Norway in collaboration with the University of Bergen. Other important sources of financial support are Helse Vest and the Norwegian Cancer Society. CCBIO is part of the Research Council of Norway's Centres of Excellence (CoE) scheme. The scheme organizes the activities of Norway’s foremost scientific circles in centres to achieve ambitious scientific objectives through collaboration and long-term basic funding.